These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17982484)

  • 1. Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
    Zhu JH; Chen R; Yi W; Cantin GT; Fearns C; Yang Y; Yates JR; Lee JD
    Oncogene; 2008 Apr; 27(18):2525-31. PubMed ID: 17982484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers.
    Vermeer PD; Bell M; Lee K; Vermeer DW; Wieking BG; Bilal E; Bhanot G; Drapkin RI; Ganesan S; Klingelhutz AJ; Hendriks WJ; Lee JH
    PLoS One; 2012; 7(1):e30447. PubMed ID: 22279592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness.
    Hamyeh M; Bernex F; Larive RM; Naldi A; Urbach S; Simony-Lafontaine J; Puech C; Bakhache W; Solassol J; Coopman PJ; Hendriks WJAJ; Freiss G
    Theranostics; 2020; 10(3):1016-1032. PubMed ID: 31938048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer.
    Scrima M; De Marco C; De Vita F; Fabiani F; Franco R; Pirozzi G; Rocco G; Malanga D; Viglietto G
    Am J Pathol; 2012 Mar; 180(3):1202-1214. PubMed ID: 22245727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway.
    Hoover AC; Strand GL; Nowicki PN; Anderson ME; Vermeer PD; Klingelhutz AJ; Bossler AD; Pottala JV; Hendriks WJ; Lee JH
    Oncogene; 2009 Nov; 28(45):3960-70. PubMed ID: 19734941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
    Long Q; Sun J; Lv J; Liang Y; Li H; Li X
    Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.
    Glondu-Lassis M; Dromard M; Lacroix-Triki M; Nirdé P; Puech C; Knani D; Chalbos D; Freiss G
    Cancer Res; 2010 Jun; 70(12):5116-26. PubMed ID: 20501847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma.
    Han X; Xue L; Zhou L; Gong L; Zhu S; Yao L; Wang S; Lan M; Li Y; Zhang W
    Exp Mol Pathol; 2013 Dec; 95(3):270-5. PubMed ID: 23906871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer.
    Mcheik S; Aptecar L; Coopman P; D'Hondt V; Freiss G
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33322542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth.
    Spanos WC; Hoover A; Harris GF; Wu S; Strand GL; Anderson ME; Klingelhutz AJ; Hendriks W; Bossler AD; Lee JH
    J Virol; 2008 Mar; 82(5):2493-500. PubMed ID: 18160445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTPN13/PTPL1: an important regulator of tumor aggressiveness.
    Freiss G; Chalbos D
    Anticancer Agents Med Chem; 2011 Jan; 11(1):78-88. PubMed ID: 21235435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tyrosine phosphatase PTPN13/FAP-1 links calpain-2, TBI and tau tyrosine phosphorylation.
    Wang Y; Hall RA; Lee M; Kamgar-Parsi A; Bi X; Baudry M
    Sci Rep; 2017 Sep; 7(1):11771. PubMed ID: 28924170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN-PDZ domain interactions: binding of PTEN to PDZ domains of PTPN13.
    Sotelo NS; Schepens JT; Valiente M; Hendriks WJ; Pulido R
    Methods; 2015 May; 77-78():147-56. PubMed ID: 25448478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance.
    Zhan H; Jiang J; Luo C; Sun Q; Ke A; Sun C; Hu J; Hu Z; Hu B; Zhu K; Fan J; Zhou J; Huang X
    Tumour Biol; 2016 Jul; 37(7):9691-8. PubMed ID: 26801674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching of the substrate specificity of protein tyrosine phosphatase N12 by cyclin-dependent kinase 2 phosphorylation orchestrating 2 oncogenic pathways.
    Li H; Yang D; Ning S; Xu Y; Yang F; Yin R; Feng T; Han S; Guo L; Zhang P; Qu W; Guo R; Song C; Xiao P; Zhou C; Xu Z; Sun JP; Yu X
    FASEB J; 2018 Jan; 32(1):73-82. PubMed ID: 28842430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of protein tyrosine phosphatase nonreceptor type 13 in the control of oocyte meiotic maturation.
    Nedachi T; Conti M
    Development; 2004 Oct; 131(20):4987-98. PubMed ID: 15371306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion.
    Benlimame N; He Q; Jie S; Xiao D; Xu YJ; Loignon M; Schlaepfer DD; Alaoui-Jamali MA
    J Cell Biol; 2005 Nov; 171(3):505-16. PubMed ID: 16275754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cells.
    Ludyga N; Anastasov N; Rosemann M; Seiler J; Lohmann N; Braselmann H; Mengele K; Schmitt M; Höfler H; Aubele M
    Mol Cancer Res; 2013 Apr; 11(4):381-92. PubMed ID: 23364537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation.
    Dromard M; Bompard G; Glondu-Lassis M; Puech C; Chalbos D; Freiss G
    Cancer Res; 2007 Jul; 67(14):6806-13. PubMed ID: 17638892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.
    Wang SE; Narasanna A; Perez-Torres M; Xiang B; Wu FY; Yang S; Carpenter G; Gazdar AF; Muthuswamy SK; Arteaga CL
    Cancer Cell; 2006 Jul; 10(1):25-38. PubMed ID: 16843263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.